Synmosa Biopharma Corporation
TWO: 4114.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Zhihui Lin
- Employees
- 495
- Headquarters
- Taipei, Taiwan
- IPO year
- 2007
- Market cap
- NT$15.6B
- Website
- https://www.synmosa.com.tw
Loading 4114…
Loading profile data…Frequently asked questions about 4114
What does Synmosa Biopharma Corporation (4114.TWO) do?
Synmosa Biopharma Corporation, a specialty pharmaceutical company, researches and develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand name in Taiwan. It offers its products in various therapeutic areas, including cardiovascular, respiratory, urology, sex hormone, and oncology. The compa...
Where does 4114.TWO trade?
Synmosa Biopharma Corporation (4114.TWO) trades on the Taipei Exchange.
What sector is 4114.TWO in?
Synmosa Biopharma Corporation (4114.TWO) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Synmosa Biopharma Corporation?
Zhihui Lin is the chief executive officer of Synmosa Biopharma Corporation (4114.TWO).
Where is Synmosa Biopharma Corporation headquartered?
Synmosa Biopharma Corporation is headquartered in Taiwan.
Does 4114.TWO pay a dividend?
Yes — Synmosa Biopharma Corporation (4114.TWO) paid a trailing twelve-month dividend of TWD 0.60 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 4114.TWO go public?
Synmosa Biopharma Corporation (4114.TWO) completed its initial public offering in 2007.